| Overview |
| bs-43192P-APC-100ug |
| Recombinant SARS-Cov-2 Spike protein(BA.2.86), (HEK293), APC Conjugated |
| Others |
| Others |
| Specifications |
| APC |
| Recombinant SARS-Cov-2 Spike protein(BA.2.86) is expressed in HEK293 cell with C-T4 foldon domain&His. It contains the amino acid sequence of 16-1213/1273 |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Target |
| P0DTC2 |
| The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct. |
Powered by Bioz